Immunodeficiency 81

Mendelian MONDO:0030302 Pathograph 32 Show in embeddings browser Primary immunodeficiency Combined immunodeficiency

Immunodeficiency 81 is an autosomal recessive inborn error of immunity caused by biallelic loss-of-function variants in LCP2, the gene encoding SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa). SLP-76 is a cytosolic scaffold adaptor that sits immediately downstream of the T-cell receptor (TCR): once the receptor engages antigen and ZAP-70 phosphorylates the transmembrane adaptor LAT, SLP-76 is recruited into the LAT-SLP-76 signalosome, where it nucleates the assembly that activates phospholipase C-gamma-1 (PLCgamma1), calcium flux, and the ERK/MAP-kinase cascade. Because SLP-76 is the point at which these proximal signals converge, its loss collapses TCR signal transduction and, in parallel, the analogous immunoreceptor and integrin pathways in neutrophils and platelets on which SLP-76 is also required. The disease was first defined in 2021 in an infant with biallelic LCP2 mutations presenting with early-onset life-threatening infections, combined T- and B-cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation. Subsequently reported patients broaden the spectrum: a homozygous frameshift patient developed EBV-driven diffuse large B-cell lymphoma, and a compound heterozygous patient had a milder combined immunodeficiency with autoimmunity and inflammatory bowel disease but normal platelet function, showing that the platelet arm is not obligate. The mechanism is developmental as well as activational: in the mouse Slp76 knockout, thymocyte maturation is blocked at the double-negative 3 stage, with resulting absence of CD4+CD8+ double-positive thymocytes and peripheral T cells, because SLP-76 integrates the pre-TCR signals that drive double-positive thymocyte expansion. IMD81 is very rare, with only a handful of reported kindreds. The clinical severity ranges from a T-B+ severe combined immunodeficiency phenotype to a later-onset combined immunodeficiency with immune dysregulation.

Ask OpenScientist

Ask a research question about Immunodeficiency 81. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
9
Pathophys.
16
Phenotypes
1
Gaps
32
Pathograph
1
Genes
4
Medical Actions
2
Models
4
References
šŸ‘Ŗ

Inheritance

1
Autosomal recessive HP:0000007
IMD81 is inherited in an autosomal recessive manner; reported patients carry homozygous or compound heterozygous loss-of-function variants in LCP2.
Autosomal recessive inheritance
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Here, we describe an infant with severe immunodeficiency who was found to have novel biallelic mutations in SLP76."
Biallelic (recessive) mutations in the index patient support autosomal recessive inheritance.
?

Discussions and Knowledge Gaps

1
The germline Slp76-null mouse shows a complete thymic block with no peripheral T cells and entirely normal B-cell development, whereas human IMD81 patients retain (dysregulated) peripheral T cells and have a B-cell antigen-receptor signaling defect with reduced memory B cells and antibody deficiency. Does the complete-null mouse therefore fail to model the human B-cell arm and overstate the T-cell developmental block, and is the human phenotype instead captured by hypomorphic Lcp2 alleles?
HUMAN MODEL MISMATCH OPEN slp76_mouse_human_bcell_and_thymic_divergence
This is a model-evidence-exists-and-diverges situation, not an absence of data. The complete Slp76 null causes an absolute block at the double-negative 3 stage with no peripheral T cells and normal B-cell development, while human patients carry hypomorphic or leaky alleles (splice, frameshift, proline-rich-domain missense) that leave residual SLP-76 and, consequently, dysregulated peripheral T cells skewed toward CD8 TEMRA plus a B-cell receptor signaling defect the null does not show. Homozygous Lcp2 splice-hypomorph mice that retain about 10% of wild-type SLP-76 protein reproduce the human pattern far better (a partial thymic block with dysregulated peripheral T cells), indicating that model fidelity to IMD81 depends on residual protein rather than on complete ablation. The B-cell arm of the human disease is therefore best modeled in patient cells and in the J14 line, not in the null mouse.
Proposed experiments
Knock-in mouse carrying a human hypomorphic LCP2 allele
exp_slp76_hypomorph_knockin
Generate a mouse expressing an actual human IMD81 hypomorphic allele (e.g. the proline-rich-domain missense or the leaky splice variant) rather than a complete null, and test whether it reproduces the human combination of dysregulated peripheral T cells and a B-cell antigen-receptor signaling defect.
B-cell antigen-receptor signaling in a residual-protein model
exp_slp76_bcr_signaling
Measure BCR-induced calcium flux and class-switch/memory B-cell generation in a residual-SLP-76 model to determine whether the human B-cell phenotype requires partial rather than complete loss of the adaptor.
āš™

Pathophysiology

9
LCP2 Biallelic Loss of Function
Biallelic loss-of-function variants in LCP2 reduce or abolish functional SLP-76 protein. Frameshift alleles eliminate the protein; missense alleles in the proline-rich repeat domain reduce its expression and signalosome function.
Genetic context LCP2 hgnc:6529 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns LCP2 (hgnc:6529). hgnc:6529 is a gene from the HUGO Gene Nomenclature Committee. allele_type: frameshift, splice-site, and proline-rich-domain missense functional_impact_category: LOSS_OF_FUNCTION
Show evidence (1 reference)
PMID:33231617 SUPPORT In Vitro
"Complete loss of SLP76 protein expression was detected by both Western blot"
Directly demonstrates that the biallelic LCP2 lesion abolishes SLP-76 protein in the index patient's cells, the molecular event this node describes.
Loss of SLP-76 Adaptor Function
SLP-76 is a scaffold adaptor that, once recruited to phosphorylated LAT, nucleates the proximal TCR signalosome. Loss of the protein removes this assembly point for downstream TCR (and other hematopoietic immunoreceptor) signaling.
SLP-76 signaling adaptor activity GO:0035591 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves SLP-76 signaling adaptor activity, annotated with signaling adaptor activity (GO:0035591), qualified as loss of function. GO:0035591 is a molecular function from the Gene Ontology. ⇓ LOSS OF FUNCTION
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"SLP76 is a key protein involved in TCR signaling and in other hematopoietic pathways."
Identifies SLP-76 as a central adaptor for TCR and other hematopoietic signaling, whose loss removes the signalosome assembly point.
Impaired Proximal TCR Signaling
Without SLP-76, the LAT-SLP-76 signalosome fails to activate PLCgamma1, so downstream calcium mobilization and ERK/MAP-kinase signaling are blunted. Patient T and B cells show reduced ligand-induced phospho-PLCgamma1 and phospho-S6, and a SLP76-deficient T-cell line shows reduced ERK1/2 phosphorylation, CD69 induction, and calcium mobilization.
T cell receptor signaling pathway GO:0050852 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased T cell receptor signaling pathway (GO:0050852). GO:0050852 is a biological process from the Gene Ontology. ↓ DECREASED positive regulation of cytosolic calcium ion concentration GO:0007204 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased positive regulation of cytosolic calcium ion concentration (GO:0007204). GO:0007204 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (3 references)
PMID:37211057 SUPPORT Human Clinical
"Tonic and ligand-induced levels of phosphorylated ribosomal protein S6 and ligand-induced phosphorylated PLCγ1 were decreased in the patient's B cells and CD4+ and CD8+ T cells."
Directly shows impaired proximal antigen-receptor signaling (PLCgamma1, S6) in patient lymphocytes.
PMID:36474126 SUPPORT In Vitro
"Downstream TCR signaling events, including ERK1/2 phosphorylation, CD69 expression, and Ca2 + mobilization, were reduced in cells harboring the reported mutation"
A SLP76-deficient Jurkat-derived T-cell line reconstituted with the patient mutation shows the reduced proximal TCR signaling this node describes.
PMID:33231617 SUPPORT Human Clinical
"downstream events, including the phosphorylation of ERK, PLC-γ1, and phospho-S6, all of which are dependent on the assembly of the LAT and SLP76 complex, were significantly reduced or absent"
Confirms in the index patient's primary T cells that ERK, PLC-gamma1 and S6 phosphorylation downstream of the LAT-SLP76 signalosome are lost.
Impaired Thymic T-Cell Development
SLP-76 integrates the pre-TCR signals that drive expansion of CD4+CD8+ double-positive thymocytes. In the mouse Slp76 knockout, thymocyte development is blocked at the double-negative 3 stage, with resulting absence of CD4+CD8+ double-positive thymocytes and peripheral T cells, providing the developmental basis for the T-cell lymphopenia seen in severe human cases.
CD4+CD8+ double-positive thymocyte CL:0000809 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves CD4+CD8+ double-positive thymocyte, annotated with double-positive, alpha-beta thymocyte (CL:0000809). CL:0000809 is a cell type from the Cell Ontology.
T cell differentiation in thymus GO:0033077 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased T cell differentiation in thymus (GO:0033077). GO:0033077 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (3 references)
PMID:33231617 SUPPORT INDIRECT Model Organism
"In the SLP76-deficient mouse model, thymocyte development was blocked at the double-negative 3 stage, resulting in the absence of peripheral T cells."
States the stage of the mouse thymic block (double-negative 3) that this node's description reflects; a non-human model, hence indirect for the human disease.
PMID:9695951 SUPPORT INDIRECT Model Organism
"Analysis of lymphoid cells revealed a profound block in thymic development with absence of double-positive CD4+8+ thymocytes and of peripheral T cells."
The Slp76-null mouse establishes that loss of SLP-76 blocks thymic T-cell development, with resulting absence of double-positive thymocytes; a non-human model, hence indirect for the human disease.
PMID:9695951 SUPPORT INDIRECT Model Organism
"These results indicate that SLP-76 collects all pre-TCR signals that drive the development and expansion of double-positive thymocytes."
Identifies the developmental mechanism (pre-TCR signal integration) by which SLP-76 loss impairs thymic T-cell development.
Defective T-Cell Activation
Mature T cells that do develop cannot be properly activated through the TCR because the SLP-76 signalosome is required to couple receptor engagement to calcium/ERK signaling and activation-marker induction.
T cell activation GO:0042110 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased T cell activation (GO:0042110). GO:0042110 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:36474126 SUPPORT In Vitro
"In order to examine the effect of this new SLP76 mutation on T cell signaling, a SLP76-deficient Jurkat-derived T cell line was transduced either with wild-type (WT), or with the specific SLP76 mutant, or with a mock vector."
Establishes the SLP76-deficient T-cell activation model whose reduced activation readouts (ERK, CD69, calcium) indicate defective T-cell activation.
Combined T- and B-Cell Immunodeficiency
The convergence of impaired T-cell development and activation, together with defective T-cell help for B cells, produces a combined immunodeficiency with failure of protective immunity. B-cell antigen-receptor signaling is itself impaired by SLP-76 loss, and specific antibody deficiency with reduced IgA and memory B cells is seen even when circulating cell numbers are near-normal.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"Biallelic variants in LCP2 impair neutrophil function and T-cell and B-cell antigen-receptor signaling and can cause combined immunodeficiency with early-onset immune dysregulation, even in the absence of platelet defects."
States that biallelic LCP2 loss impairs both T- and B-cell receptor signaling and causes combined immunodeficiency, the central disease phenotype.
Neutrophil Functional Defect
SLP-76 is also required in myeloid immunoreceptor and integrin signaling, so its loss impairs neutrophil reactive-oxygen-species production, integrin-dependent spreading and chemotaxis independently of the lymphocyte defect, contributing to bacterial and fungal susceptibility.
neutrophil CL:0000775 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neutrophil (CL:0000775). CL:0000775 is a cell type from the Cell Ontology.
Show evidence (3 references)
PMID:37211057 SUPPORT Human Clinical
"However, neutrophil function, numbers of unswitched and class-switched memory B cells, and serum IgA were decreased."
Documents reduced neutrophil function (and B-cell/IgA deficits) in a patient with biallelic LCP2 variants.
PMID:33231617 SUPPORT Human Clinical
"These results suggest a substantial defect in proximal neutrophil signaling, which may be partially bypassed by PMA stimulation."
The index patient's neutrophils show a proximal signaling defect, directly supporting the neutrophil functional defect this node represents.
PMID:33231617 SUPPORT INDIRECT Model Organism
"SLP76-deficient neutrophils have shown decreased Fcγ receptor-dependent and adhesion-dependent production of reactive oxygen intermediates and decreased integrin-dependent spreading"
Provides the ROS/integrin mechanism by which SLP-76 loss impairs neutrophil function; based on SLP76-deficient (murine) neutrophils, hence indirect.
Defective Platelet GPVI/Integrin Signaling
SLP-76 transmits signals from the platelet collagen receptor GPVI and integrin pathways, so its loss impairs platelet activation and aggregation. This arm is present in the severe index case but was spared in a milder compound-heterozygous patient, so it is not obligate.
platelet CL:0000233 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves platelet (CL:0000233). CL:0000233 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:33231617 SUPPORT Human Clinical
"Nevertheless, platelet aggregation was reduced, specifically in response to collagen (Table S1)."
Reports the collagen-specific platelet aggregation defect in the index patient, the functional consequence this node represents.
PMID:33231617 SUPPORT INDIRECT Other
"It is known that SLP76 is required for signaling downstream of glycoprotein VI, which is an ITAM-bearing collagen receptor expressed by platelets"
Identifies GPVI, the collagen receptor whose SLP-76-dependent signaling is lost, as the molecular basis of the collagen-specific platelet defect.
Susceptibility to EBV-Driven Lymphoproliferation
Loss of cytotoxic T-cell surveillance in combined immunodeficiency permits uncontrolled Epstein-Barr virus infection and EBV-driven B-cell proliferation, which in one reported patient progressed to diffuse large B-cell lymphoma.
Show evidence (1 reference)
PMID:36474126 SUPPORT Human Clinical
"SLP76 deficiency should be added to the growing list of monogenetic diseases that predispose affected individuals to acquire severe and uncontrolled EBV infections and to develop substantial complications."
States that SLP76 deficiency predisposes to severe, uncontrolled EBV infection, the basis for EBV-driven lymphoproliferation.
⬔

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Immunodeficiency 81 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
ā—

Phenotypes

16
Blood 10
Abnormal neutrophil physiology HP:0011990 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neutrophil functional defect, annotated with Abnormal neutrophil physiology (HP:0011990). HP:0011990 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"However, neutrophil function, numbers of unswitched and class-switched memory B cells, and serum IgA were decreased."
Reports decreased neutrophil function in a patient with biallelic LCP2 variants.
Impaired platelet aggregation HP:0003540 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Impaired platelet aggregation (HP:0003540). HP:0003540 is a phenotype from the Human Phenotype Ontology.
Sequelae: Bleeding tendency
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Our current study links this gene, for the first time, to a human immunodeficiency characterized by early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation."
Reports impaired platelet aggregation in the index SLP76-deficient patient.
Bleeding tendency Abnormal bleeding HP:0001892 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bleeding tendency, annotated with Abnormal bleeding (HP:0001892). HP:0001892 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"The bleeding tendency that was observed in our patient is probably due to decreased collagen-induced platelet aggregation and granule release"
Reports a bleeding tendency in the index patient linked to the platelet defect.
Inverted CD4:CD8 ratio HP:0033222 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Inverted CD4:CD8 ratio (HP:0033222). HP:0033222 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"lymphocyte immune phenotyping showed a high proportion of CD8 T cells and a very low proportion of CD4 T cells"
Reports the inverted CD4:CD8 proportion in the index patient.
Decreased mitogen-induced T-cell proliferation HP:0031381 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Absent mitogen-induced T-cell proliferation, annotated with Decreased mitogen-induced T-cell proliferation (HP:0031381). HP:0031381 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Peripheral lymphocyte proliferation, as determined by either thymidine incorporation or CFSE, was absent in response to PHA or anti-CD3, with or without anti-CD28"
Reports absent mitogen/anti-CD3-induced lymphocyte proliferation in the index patient.
Reduced natural killer cell degranulation Abnormal natural killer cell physiology HP:0012177 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Reduced natural killer cell degranulation, annotated with Abnormal natural killer cell physiology (HP:0012177). HP:0012177 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"K562-induced degranulation was diminished, as reflected in degranulation-associated surface expression of CD107a"
Reports reduced NK cell degranulation (CD107a) in the index patient.
Abnormally low TREC level Abnormally low T cell receptor excision circle level HP:0031545 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Low T-cell receptor excision circles, annotated with Abnormally low T cell receptor excision circle level (HP:0031545). HP:0031545 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Thymic activity, as determined by TCR excision circles quantification, was low"
Reports low TRECs (reduced thymic output) in the index patient.
Decreased circulating IgA concentration HP:0002720 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased circulating IgA concentration (HP:0002720). HP:0002720 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"However, neutrophil function, numbers of unswitched and class-switched memory B cells, and serum IgA were decreased."
Reports decreased serum IgA in a patient with biallelic LCP2 variants.
Decreased class-switched memory B cell proportion HP:0030388 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Decreased class-switched memory B cell proportion (HP:0030388). HP:0030388 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"However, neutrophil function, numbers of unswitched and class-switched memory B cells, and serum IgA were decreased."
Reports decreased class-switched memory B cells in a patient with biallelic LCP2 variants.
B-cell lymphoma HP:0012191 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is EBV-related diffuse large B-cell lymphoma, annotated with B-cell lymphoma (HP:0012191). HP:0012191 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36474126 SUPPORT Human Clinical
"presented with recurrent infections, failure to thrive, and severe EBV-related infection and proliferation. A diagnosis of diffuse large B cell lymphoma was made"
Reports EBV-related diffuse large B-cell lymphoma in an SLP76-deficient patient.
Digestive 1
Colitis HP:0002583 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Colitis (HP:0002583). HP:0002583 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"a 26-year-old man who presented with specific antibody deficiency, autoimmunity, and inflammatory bowel disease since early childhood."
Reports inflammatory bowel disease in an LCP2-deficient patient.
Immune 4
Combined immunodeficiency HP:0005387 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Combined immunodeficiency (HP:0005387). HP:0005387 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Our current study links this gene, for the first time, to a human immunodeficiency characterized by early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation."
Reports combined T- and B-cell immunodeficiency as the defining phenotype.
Recurrent infections HP:0002719 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Recurrent infections (HP:0002719). HP:0002719 is a phenotype from the Human Phenotype Ontology.
Sequelae: Failure to thrive
Show evidence (1 reference)
PMID:36474126 SUPPORT Human Clinical
"presented with recurrent infections, failure to thrive, and severe EBV-related infection and proliferation."
Reports recurrent infections in an LCP2/SLP76-deficient patient.
Fungal brain abscess HP:0030049 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fungal (Aspergillus) brain abscess, annotated with Brain abscess (HP:0030049). HP:0030049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Our patient developed fungal brain abscesses, likely due to a specific defect in neutrophil function"
Reports fungal brain abscesses attributed to the neutrophil defect in the index patient.
Autoimmunity HP:0002960 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Autoimmunity (HP:0002960). HP:0002960 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37211057 SUPPORT Human Clinical
"a 26-year-old man who presented with specific antibody deficiency, autoimmunity, and inflammatory bowel disease since early childhood."
Reports autoimmunity in an LCP2-deficient patient with immune dysregulation.
Growth 1
Failure to thrive HP:0001508 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Failure to thrive (HP:0001508). HP:0001508 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36474126 SUPPORT Human Clinical
"presented with recurrent infections, failure to thrive, and severe EBV-related infection and proliferation."
Reports failure to thrive in an LCP2/SLP76-deficient patient.
🧬

Genetic Associations

1
LCP2 (CAUSATIVE)
Gene: LCP2 hgnc:6529 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is LCP2 (hgnc:6529). hgnc:6529 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE
Show evidence (3 references)
PMID:33231617 SUPPORT Human Clinical
"Here, we describe an infant with severe immunodeficiency who was found to have novel biallelic mutations in SLP76."
Documents biallelic (recessive) LCP2/SLP76 mutations in the index patient.
PMID:36474126 SUPPORT Human Clinical
"Whole-exome sequencing revealed a novel homozygous mutation, c.991del.C; p. Q331Sfs*6 in the SLP76 gene."
A homozygous frameshift allele, one of the loss-of-function genotypes reported for IMD81.
PMID:37211057 SUPPORT Human Clinical
"Compound heterozygous missense variants were identified in LCP2, affecting the proline-rich repeat domain of SLP76 (p.P190R and p.R204W)."
A compound-heterozygous genotype affecting the SLP-76 proline-rich repeat domain, confirming biallelic LCP2 as causal and extending the allelic spectrum.
šŸ—ƒļø

External Assertions

1
OMIM immunodeficiency 81 record
OMIM disease record OMIM:619374
OMIM phenotype identifier for immunodeficiency 81 (IMD81), the LCP2/SLP-76 deficiency phenotype.
šŸ’Š

Medical Actions

4
Hematopoietic Stem Cell Transplantation
Action: hematopoietic stem cell transplantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hematopoietic stem cell transplantation, annotated with Hematopoietic Cell Transplantation (NCIT:C15431). NCIT:C15431 is a clinical intervention from the NCI Thesaurus. Ontology label: Hematopoietic Cell Transplantation NCIT:C15431
Platform: Cell therapy
Allogeneic hematopoietic stem cell transplantation is the definitive treatment for the severe combined immunodeficiency form, replacing the SLP-76-deficient hematopoietic compartment. The index infant underwent haplo-identical HSCT but died of transplant-related complications; HSCT is the standard curative approach for T-B+ SCID generally.
Mechanism Target:
RESTORES Loss of SLP-76 Adaptor Function — Allogeneic HSCT replaces the SLP-76-deficient hematopoietic compartment with donor cells that express functional SLP-76, restoring the adaptor at the root of the disease mechanism.
Antimicrobial Prophylaxis and Treatment
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: anti-infective agent NCIT:C254 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses anti-infective agent (NCIT:C254). NCIT:C254 is a therapeutic agent from the NCI Thesaurus.
Platform: Small molecule
Broad antibacterial, antiviral, and antifungal prophylaxis and treatment to manage the recurrent and opportunistic infections of the combined immune and neutrophil defect.
Mechanism Target:
INHIBITS Recurrent infections — Antibacterial, antiviral, and antifungal agents treat and prevent the recurrent opportunistic infections that result from the combined immune and neutrophil defect.
Immunoglobulin Replacement Therapy
Action: immunoglobulin replacement therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is immunoglobulin replacement therapy, annotated with Immunoglobulin Therapy (NCIT:C62710). NCIT:C62710 is a clinical intervention from the NCI Thesaurus. Ontology label: Immunoglobulin Therapy NCIT:C62710
Platform: Protein replacement
Immunoglobulin replacement supports the humoral immunodeficiency (antibody deficiency, reduced IgA and memory B cells) seen in these patients.
Mechanism Target:
BYPASSES Combined T- and B-Cell Immunodeficiency — Passive immunoglobulin replaces the antibody the patient cannot make, bypassing the humoral arm of the combined immunodeficiency rather than correcting the underlying signaling defect.
Supportive and Oncologic Care
Action: supportive careNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is supportive care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. Ontology label: Supportive Care NCIT:C15747
Supportive care and, when EBV-driven lymphoproliferation or lymphoma develops, directed oncologic therapy. One reported patient developed and succumbed to EBV-related diffuse large B-cell lymphoma.
Mechanism Target:
INHIBITS B-cell lymphoma — Directed oncologic therapy targets the EBV-driven B-cell lymphoma that arises as a downstream complication of the immunodeficiency.
šŸ“Š

Prevalence

1
Worldwide
Cases In Literature Ultra Rare
An ultra-rare entity. LCP2/SLP-76 deficiency was first linked to a human disease in 2021, and only a small number of unrelated patients have since been reported (an index infant with SCID, a patient with EBV-related lymphoma, and a compound-heterozygous patient with milder combined immunodeficiency). No population rate can be derived from these case reports.
Show evidence (1 reference)
PMID:33231617 SUPPORT Human Clinical
"Our current study links this gene, for the first time, to a human immunodeficiency characterized by early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation."
Establishes IMD81 as a newly defined, first-reported human disease, consistent with an ultra-rare case-report-level entity.
🧫

Experimental Models

1
SLP76-deficient Jurkat-derived T-cell line (J14) CELL_LINE
The J14 line is the classical in vitro system for dissecting SLP-76 function downstream of the TCR. Reconstituting it with the patient's SLP-76 mutant reproduces the reduced proximal TCR signaling, and ectopic wild-type SLP-76 rescues it, linking the specific mutation to the signaling phenotype.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Cell source
J14, a SLP76-deficient subline of the Jurkat human leukemic T-cell line, reconstituted with wild-type or patient-mutant SLP-76 to model and rescue the signaling defect.
Publication
Show evidence (1 reference)
PMID:33231617 SUPPORT In Vitro
"we characterized aspects of the patient's immune phenotype, modeled them with an SLP76-deficient Jurkat-derived T cell line, and rescued some consequences using ectopic expression of wild-type SLP76."
Establishes the J14 line as the model used to reproduce and rescue the patient's TCR-signaling phenotype.
🐁

Animal Models

1
Slp76-null mouse (Lcp2 knockout)
The germline Slp76-null mouse, generated by homologous recombination, was the original in vivo model of SLP-76 loss. It exhibits impaired viability, a profound thymic developmental block, and hemorrhage. It informs the human disease but diverges from it in two ways relevant to IMD81: the complete null causes an absolute developmental block with no peripheral T cells (human hypomorphic alleles leave dysregulated peripheral T cells), and B-cell development is entirely normal (human patients have a B-cell antigen-receptor signaling defect).
Species
Mouse
Genotype
Slp76 (Lcp2) null (homozygous knockout)
Publication
Show evidence (1 reference)
PMID:9695951 SUPPORT Model Organism
"We generated a SLP-76 null mutation in mice by homologous recombination in embryonic stem cells to evaluate the role of SLP-76 in T cell development and activation."
Establishes the Slp76-null mouse as the in vivo model of SLP-76 loss informing this disease.
{ }

Source YAML

click to show
name: Immunodeficiency 81
creation_date: "2026-09-02T00:00:00Z"
category: Mendelian
synonyms:
- IMD81
- LCP2 deficiency
- SLP76 deficiency
- T-B+ severe combined immunodeficiency due to SLP76 deficiency
description: >
  Immunodeficiency 81 is an autosomal recessive inborn error of immunity caused by
  biallelic loss-of-function variants in LCP2, the gene encoding SLP-76 (SH2
  domain-containing leukocyte protein of 76 kDa). SLP-76 is a cytosolic scaffold
  adaptor that sits immediately downstream of the T-cell receptor (TCR): once the
  receptor engages antigen and ZAP-70 phosphorylates the transmembrane adaptor LAT,
  SLP-76 is recruited into the LAT-SLP-76 signalosome, where it nucleates the
  assembly that activates phospholipase C-gamma-1 (PLCgamma1), calcium flux, and the
  ERK/MAP-kinase cascade. Because SLP-76 is the point at which these proximal
  signals converge, its loss collapses TCR signal transduction and, in parallel, the
  analogous immunoreceptor and integrin pathways in neutrophils and platelets on
  which SLP-76 is also required.

  The disease was first defined in 2021 in an infant with biallelic LCP2 mutations
  presenting with early-onset life-threatening infections, combined T- and B-cell
  immunodeficiency, severe neutrophil defects, and impaired platelet aggregation.
  Subsequently reported patients broaden the spectrum: a homozygous frameshift
  patient developed EBV-driven diffuse large B-cell lymphoma, and a compound
  heterozygous patient had a milder combined immunodeficiency with autoimmunity and
  inflammatory bowel disease but normal platelet function, showing that the platelet
  arm is not obligate. The mechanism is developmental as well as activational: in
  the mouse Slp76 knockout, thymocyte maturation is blocked at the double-negative 3
  stage, with resulting absence of CD4+CD8+ double-positive thymocytes and peripheral
  T cells, because SLP-76 integrates the pre-TCR signals that drive double-positive
  thymocyte expansion.

  IMD81 is very rare, with only a handful of reported kindreds. The clinical
  severity ranges from a T-B+ severe combined immunodeficiency phenotype to a
  later-onset combined immunodeficiency with immune dysregulation.
disease_term:
  preferred_term: immunodeficiency 81
  term:
    id: MONDO:0030302
    label: immunodeficiency 81
external_assertions:
- name: OMIM immunodeficiency 81 record
  source: OMIM
  assertion_type: disease_record
  external_id: OMIM:619374
  description: >-
    OMIM phenotype identifier for immunodeficiency 81 (IMD81), the LCP2/SLP-76
    deficiency phenotype.
parents:
- Primary immunodeficiency
- Combined immunodeficiency
references:
- reference: PMID:33231617
  title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
- reference: PMID:37211057
  title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
- reference: PMID:36474126
  title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
- reference: PMID:9695951
  title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
inheritance:
- name: Autosomal recessive
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    IMD81 is inherited in an autosomal recessive manner; reported patients carry
    homozygous or compound heterozygous loss-of-function variants in LCP2.
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe an infant with severe immunodeficiency who was found to have
      novel biallelic mutations in SLP76.
    explanation: >-
      Biallelic (recessive) mutations in the index patient support autosomal
      recessive inheritance.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    An ultra-rare entity. LCP2/SLP-76 deficiency was first linked to a human disease
    in 2021, and only a small number of unrelated patients have since been reported
    (an index infant with SCID, a patient with EBV-related lymphoma, and a
    compound-heterozygous patient with milder combined immunodeficiency). No
    population rate can be derived from these case reports.
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our current study links this gene, for the first time, to a human
      immunodeficiency characterized by early-onset life-threatening infections,
      combined T and B cell immunodeficiency, severe neutrophil defects, and
      impaired platelet aggregation.
    explanation: >-
      Establishes IMD81 as a newly defined, first-reported human disease, consistent
      with an ultra-rare case-report-level entity.
genetic:
- name: LCP2
  gene_term:
    preferred_term: LCP2
    term:
      id: hgnc:6529
      label: LCP2
  association: CAUSATIVE
  variant_origin: GERMLINE
  features: >-
    Biallelic loss-of-function variants in LCP2 (encoding SLP-76) cause IMD81.
    Reported genotypes include novel biallelic mutations in the index infant, a
    homozygous frameshift (c.991delC; p.Q331Sfs*6), and compound heterozygous
    missense variants in the proline-rich repeat domain (p.P190R and p.R204W). The
    net functional consequence is loss of SLP-76 adaptor function. Inheritance is
    autosomal recessive.
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe an infant with severe immunodeficiency who was found to have
      novel biallelic mutations in SLP76.
    explanation: >-
      Documents biallelic (recessive) LCP2/SLP76 mutations in the index patient.
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Whole-exome sequencing revealed a novel homozygous mutation, c.991del.C; p.
      Q331Sfs*6 in the SLP76 gene.
    explanation: >-
      A homozygous frameshift allele, one of the loss-of-function genotypes reported
      for IMD81.
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Compound heterozygous missense variants were identified in LCP2, affecting the
      proline-rich repeat domain of SLP76 (p.P190R and p.R204W).
    explanation: >-
      A compound-heterozygous genotype affecting the SLP-76 proline-rich repeat
      domain, confirming biallelic LCP2 as causal and extending the allelic spectrum.
pathophysiology:
- name: LCP2 Biallelic Loss of Function
  biological_scale: MOLECULAR
  description: >-
    Biallelic loss-of-function variants in LCP2 reduce or abolish functional SLP-76
    protein. Frameshift alleles eliminate the protein; missense alleles in the
    proline-rich repeat domain reduce its expression and signalosome function.
  genetic_context:
    gene:
      preferred_term: LCP2
      term:
        id: hgnc:6529
        label: LCP2
    allele_type: frameshift, splice-site, and proline-rich-domain missense
    functional_impact_category: LOSS_OF_FUNCTION
  downstream:
  - target: Loss of SLP-76 Adaptor Function
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Complete loss of SLP76 protein expression was detected by both Western blot
    explanation: >-
      Directly demonstrates that the biallelic LCP2 lesion abolishes SLP-76 protein
      in the index patient's cells, the molecular event this node describes.
- name: Loss of SLP-76 Adaptor Function
  biological_scale: MOLECULAR
  description: >-
    SLP-76 is a scaffold adaptor that, once recruited to phosphorylated LAT, nucleates
    the proximal TCR signalosome. Loss of the protein removes this assembly point for
    downstream TCR (and other hematopoietic immunoreceptor) signaling.
  molecular_functions:
  - preferred_term: SLP-76 signaling adaptor activity
    term:
      id: GO:0035591
      label: signaling adaptor activity
    modifier: LOSS_OF_FUNCTION
  downstream:
  - target: Impaired Proximal TCR Signaling
    causal_link_type: DIRECT
  - target: Reduced natural killer cell degranulation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SLP76 is a key protein involved in TCR signaling and in other hematopoietic
      pathways.
    explanation: >-
      Identifies SLP-76 as a central adaptor for TCR and other hematopoietic
      signaling, whose loss removes the signalosome assembly point.
- name: Impaired Proximal TCR Signaling
  biological_scale: CELLULAR
  description: >-
    Without SLP-76, the LAT-SLP-76 signalosome fails to activate PLCgamma1, so
    downstream calcium mobilization and ERK/MAP-kinase signaling are blunted. Patient
    T and B cells show reduced ligand-induced phospho-PLCgamma1 and phospho-S6, and a
    SLP76-deficient T-cell line shows reduced ERK1/2 phosphorylation, CD69 induction,
    and calcium mobilization.
  biological_processes:
  - preferred_term: T cell receptor signaling pathway
    term:
      id: GO:0050852
      label: T cell receptor signaling pathway
    modifier: DECREASED
  - preferred_term: positive regulation of cytosolic calcium ion concentration
    term:
      id: GO:0007204
      label: positive regulation of cytosolic calcium ion concentration
    modifier: DECREASED
  downstream:
  - target: Impaired Thymic T-Cell Development
    causal_link_type: DIRECT
  - target: Defective T-Cell Activation
    causal_link_type: DIRECT
  - target: Autoimmunity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Tonic and ligand-induced levels of phosphorylated ribosomal protein S6 and
      ligand-induced phosphorylated PLCγ1 were decreased in the patient's B cells and
      CD4+ and CD8+ T cells.
    explanation: >-
      Directly shows impaired proximal antigen-receptor signaling (PLCgamma1, S6) in
      patient lymphocytes.
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Downstream TCR signaling events, including ERK1/2 phosphorylation, CD69
      expression, and Ca2 + mobilization, were reduced in cells harboring the reported
      mutation
    explanation: >-
      A SLP76-deficient Jurkat-derived T-cell line reconstituted with the patient
      mutation shows the reduced proximal TCR signaling this node describes.
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      downstream events, including the phosphorylation of ERK, PLC-γ1, and phospho-S6,
      all of which are dependent on the assembly of the LAT and SLP76 complex, were
      significantly reduced or absent
    explanation: >-
      Confirms in the index patient's primary T cells that ERK, PLC-gamma1 and S6
      phosphorylation downstream of the LAT-SLP76 signalosome are lost.
- name: Impaired Thymic T-Cell Development
  biological_scale: CELLULAR
  description: >-
    SLP-76 integrates the pre-TCR signals that drive expansion of CD4+CD8+
    double-positive thymocytes. In the mouse Slp76 knockout, thymocyte development is
    blocked at the double-negative 3 stage, with resulting absence of CD4+CD8+
    double-positive thymocytes and peripheral T cells, providing the developmental
    basis for the T-cell lymphopenia seen in severe human cases.
  cell_types:
  - preferred_term: CD4+CD8+ double-positive thymocyte
    term:
      id: CL:0000809
      label: double-positive, alpha-beta thymocyte
  biological_processes:
  - preferred_term: T cell differentiation in thymus
    term:
      id: GO:0033077
      label: T cell differentiation in thymus
    modifier: DECREASED
  downstream:
  - target: Combined T- and B-Cell Immunodeficiency
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Inverted CD4:CD8 ratio
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Abnormally low TREC level
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In the SLP76-deficient mouse model, thymocyte development was blocked at the
      double-negative 3 stage, resulting in the absence of peripheral T cells.
    explanation: >-
      States the stage of the mouse thymic block (double-negative 3) that this node's
      description reflects; a non-human model, hence indirect for the human disease.
  - reference: PMID:9695951
    reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Analysis of lymphoid cells revealed a profound block in thymic development with
      absence of double-positive CD4+8+ thymocytes and of peripheral T cells.
    explanation: >-
      The Slp76-null mouse establishes that loss of SLP-76 blocks thymic T-cell
      development, with resulting absence of double-positive thymocytes; a non-human
      model, hence indirect for the human disease.
  - reference: PMID:9695951
    reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These results indicate that SLP-76 collects all pre-TCR signals that drive the
      development and expansion of double-positive thymocytes.
    explanation: >-
      Identifies the developmental mechanism (pre-TCR signal integration) by which
      SLP-76 loss impairs thymic T-cell development.
- name: Defective T-Cell Activation
  biological_scale: CELLULAR
  description: >-
    Mature T cells that do develop cannot be properly activated through the TCR
    because the SLP-76 signalosome is required to couple receptor engagement to
    calcium/ERK signaling and activation-marker induction.
  biological_processes:
  - preferred_term: T cell activation
    term:
      id: GO:0042110
      label: T cell activation
    modifier: DECREASED
  downstream:
  - target: Combined T- and B-Cell Immunodeficiency
    causal_link_type: DIRECT
  - target: Decreased mitogen-induced T-cell proliferation
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In order to examine the effect of this new SLP76 mutation on T cell signaling, a
      SLP76-deficient Jurkat-derived T cell line was transduced either with wild-type
      (WT), or with the specific SLP76 mutant, or with a mock vector.
    explanation: >-
      Establishes the SLP76-deficient T-cell activation model whose reduced
      activation readouts (ERK, CD69, calcium) indicate defective T-cell activation.
- name: Combined T- and B-Cell Immunodeficiency
  biological_scale: ORGANISM
  description: >-
    The convergence of impaired T-cell development and activation, together with
    defective T-cell help for B cells, produces a combined immunodeficiency with
    failure of protective immunity. B-cell antigen-receptor signaling is itself
    impaired by SLP-76 loss, and specific antibody deficiency with reduced IgA and
    memory B cells is seen even when circulating cell numbers are near-normal.
  downstream:
  - target: Combined immunodeficiency
    causal_link_type: DIRECT
  - target: Recurrent infections
    causal_link_type: DIRECT
  - target: Decreased circulating IgA concentration
    causal_link_type: DIRECT
  - target: Decreased class-switched memory B cell proportion
    causal_link_type: DIRECT
  - target: Colitis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Susceptibility to EBV-Driven Lymphoproliferation
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic variants in LCP2 impair neutrophil function and T-cell and B-cell
      antigen-receptor signaling and can cause combined immunodeficiency with
      early-onset immune dysregulation, even in the absence of platelet defects.
    explanation: >-
      States that biallelic LCP2 loss impairs both T- and B-cell receptor signaling
      and causes combined immunodeficiency, the central disease phenotype.
- name: Neutrophil Functional Defect
  biological_scale: CELLULAR
  description: >-
    SLP-76 is also required in myeloid immunoreceptor and integrin signaling, so its
    loss impairs neutrophil reactive-oxygen-species production, integrin-dependent
    spreading and chemotaxis independently of the lymphocyte defect, contributing to
    bacterial and fungal susceptibility.
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  downstream:
  - target: Recurrent infections
    causal_link_type: DIRECT
  - target: Abnormal neutrophil physiology
    causal_link_type: DIRECT
  - target: Fungal brain abscess
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, neutrophil function, numbers of unswitched and class-switched memory B
      cells, and serum IgA were decreased.
    explanation: >-
      Documents reduced neutrophil function (and B-cell/IgA deficits) in a patient
      with biallelic LCP2 variants.
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results suggest a substantial defect in proximal neutrophil signaling,
      which may be partially bypassed by PMA stimulation.
    explanation: >-
      The index patient's neutrophils show a proximal signaling defect, directly
      supporting the neutrophil functional defect this node represents.
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      SLP76-deficient neutrophils have shown decreased Fcγ receptor-dependent and
      adhesion-dependent production of reactive oxygen intermediates and decreased
      integrin-dependent spreading
    explanation: >-
      Provides the ROS/integrin mechanism by which SLP-76 loss impairs neutrophil
      function; based on SLP76-deficient (murine) neutrophils, hence indirect.
- name: Defective Platelet GPVI/Integrin Signaling
  biological_scale: CELLULAR
  description: >-
    SLP-76 transmits signals from the platelet collagen receptor GPVI and integrin
    pathways, so its loss impairs platelet activation and aggregation. This arm is
    present in the severe index case but was spared in a milder compound-heterozygous
    patient, so it is not obligate.
  cell_types:
  - preferred_term: platelet
    term:
      id: CL:0000233
      label: platelet
  downstream:
  - target: Impaired platelet aggregation
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Nevertheless, platelet aggregation was reduced, specifically in response to
      collagen (Table S1).
    explanation: >-
      Reports the collagen-specific platelet aggregation defect in the index patient,
      the functional consequence this node represents.
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: >-
      It is known that SLP76 is required for signaling downstream of glycoprotein VI,
      which is an ITAM-bearing collagen receptor expressed by platelets
    explanation: >-
      Identifies GPVI, the collagen receptor whose SLP-76-dependent signaling is lost,
      as the molecular basis of the collagen-specific platelet defect.
- name: Susceptibility to EBV-Driven Lymphoproliferation
  biological_scale: ORGANISM
  description: >-
    Loss of cytotoxic T-cell surveillance in combined immunodeficiency permits
    uncontrolled Epstein-Barr virus infection and EBV-driven B-cell proliferation,
    which in one reported patient progressed to diffuse large B-cell lymphoma.
  downstream:
  - target: B-cell lymphoma
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SLP76 deficiency should be added to the growing list of monogenetic diseases
      that predispose affected individuals to acquire severe and uncontrolled EBV
      infections and to develop substantial complications.
    explanation: >-
      States that SLP76 deficiency predisposes to severe, uncontrolled EBV infection,
      the basis for EBV-driven lymphoproliferation.
phenotypes:
- name: Combined immunodeficiency
  category: Immunological
  description: >-
    Combined defect of T- and B-cell immunity, ranging from a T-B+ severe combined
    immunodeficiency presentation to a milder later-onset combined immunodeficiency.
  phenotype_term:
    preferred_term: Combined immunodeficiency
    term:
      id: HP:0005387
      label: Combined immunodeficiency
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our current study links this gene, for the first time, to a human
      immunodeficiency characterized by early-onset life-threatening infections,
      combined T and B cell immunodeficiency, severe neutrophil defects, and
      impaired platelet aggregation.
    explanation: >-
      Reports combined T- and B-cell immunodeficiency as the defining phenotype.
- name: Recurrent infections
  category: Immunological
  description: >-
    Early-onset, recurrent, and life-threatening bacterial, viral, and other
    infections reflecting the combined immune defect.
  phenotype_term:
    preferred_term: Recurrent infections
    term:
      id: HP:0002719
      label: Recurrent infections
  sequelae:
  - target: Failure to thrive
    description: >-
      Recurrent, severe early-onset infection drives the failure to thrive seen in
      infancy.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      presented with recurrent infections, failure to thrive, and severe EBV-related
      infection and proliferation.
    explanation: >-
      Reports recurrent infections in an LCP2/SLP76-deficient patient.
- name: Failure to thrive
  category: Constitutional
  description: >-
    Failure to thrive in infancy/early childhood, a common consequence of severe
    early-onset immunodeficiency.
  phenotype_term:
    preferred_term: Failure to thrive
    term:
      id: HP:0001508
      label: Failure to thrive
  evidence:
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      presented with recurrent infections, failure to thrive, and severe EBV-related
      infection and proliferation.
    explanation: >-
      Reports failure to thrive in an LCP2/SLP76-deficient patient.
- name: Abnormal neutrophil physiology
  category: Immunological
  description: >-
    Severe neutrophil functional defects contribute to infection susceptibility
    independent of the lymphocyte defect.
  phenotype_term:
    preferred_term: Neutrophil functional defect
    term:
      id: HP:0011990
      label: Abnormal neutrophil physiology
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, neutrophil function, numbers of unswitched and class-switched memory B
      cells, and serum IgA were decreased.
    explanation: >-
      Reports decreased neutrophil function in a patient with biallelic LCP2 variants.
- name: Fungal brain abscess
  category: Immunological
  description: >-
    Invasive fungal (Aspergillus) brain abscesses developed in the index infant,
    reflecting the severe neutrophil defect. Bound to the structural Brain abscess
    HP term; the fungal etiology is carried in the preferred_term.
  phenotype_term:
    preferred_term: Fungal (Aspergillus) brain abscess
    term:
      id: HP:0030049
      label: Brain abscess
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our patient developed fungal brain abscesses, likely due to a specific defect
      in neutrophil function
    explanation: >-
      Reports fungal brain abscesses attributed to the neutrophil defect in the index
      patient.
- name: Impaired platelet aggregation
  category: Hematological
  description: >-
    Impaired platelet aggregation from defective SLP-76-dependent platelet signaling,
    present in the severe index case but not in all reported patients.
  phenotype_term:
    preferred_term: Impaired platelet aggregation
    term:
      id: HP:0003540
      label: Impaired platelet aggregation
  sequelae:
  - target: Bleeding tendency
    description: >-
      Reduced collagen-induced platelet aggregation and granule release produce the
      bleeding tendency observed clinically.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our current study links this gene, for the first time, to a human
      immunodeficiency characterized by early-onset life-threatening infections,
      combined T and B cell immunodeficiency, severe neutrophil defects, and
      impaired platelet aggregation.
    explanation: >-
      Reports impaired platelet aggregation in the index SLP76-deficient patient.
- name: Bleeding tendency
  category: Hematological
  description: >-
    A bleeding tendency (petechial rash) in the index infant, attributed to defective
    collagen-induced platelet aggregation and granule release.
  phenotype_term:
    preferred_term: Bleeding tendency
    term:
      id: HP:0001892
      label: Abnormal bleeding
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The bleeding tendency that was observed in our patient is probably due to
      decreased collagen-induced platelet aggregation and granule release
    explanation: >-
      Reports a bleeding tendency in the index patient linked to the platelet defect.
- name: Inverted CD4:CD8 ratio
  category: Immunological
  description: >-
    A skewed peripheral T-cell compartment with a high proportion of CD8 T cells and
    a very low proportion of CD4 T cells in the index infant.
  phenotype_term:
    preferred_term: Inverted CD4:CD8 ratio
    term:
      id: HP:0033222
      label: Inverted CD4:CD8 ratio
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      lymphocyte immune phenotyping showed a high proportion of CD8 T cells and a very
      low proportion of CD4 T cells
    explanation: >-
      Reports the inverted CD4:CD8 proportion in the index patient.
- name: Decreased mitogen-induced T-cell proliferation
  category: Immunological
  description: >-
    Absent peripheral lymphocyte proliferation to PHA or anti-CD3 (with or without
    anti-CD28) in the index infant, partially restored by exogenous IL-2.
  phenotype_term:
    preferred_term: Absent mitogen-induced T-cell proliferation
    term:
      id: HP:0031381
      label: Decreased mitogen-induced T-cell proliferation
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Peripheral lymphocyte proliferation, as determined by either thymidine
      incorporation or CFSE, was absent in response to PHA or anti-CD3, with or without
      anti-CD28
    explanation: >-
      Reports absent mitogen/anti-CD3-induced lymphocyte proliferation in the index
      patient.
- name: Reduced natural killer cell degranulation
  category: Immunological
  description: >-
    Normal NK cell numbers but diminished K562-induced degranulation (surface CD107a)
    in the index infant, partially rescued by IL-2.
  phenotype_term:
    preferred_term: Reduced natural killer cell degranulation
    term:
      id: HP:0012177
      label: Abnormal natural killer cell physiology
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      K562-induced degranulation was diminished, as reflected in
      degranulation-associated surface expression of CD107a
    explanation: >-
      Reports reduced NK cell degranulation (CD107a) in the index patient.
- name: Abnormally low TREC level
  category: Immunological
  description: >-
    Low thymic output measured by TCR excision circle (TREC) quantification in the
    index infant, consistent with impaired thymic T-cell development.
  phenotype_term:
    preferred_term: Low T-cell receptor excision circles
    term:
      id: HP:0031545
      label: Abnormally low T cell receptor excision circle level
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thymic activity, as determined by TCR excision circles quantification, was low
    explanation: >-
      Reports low TRECs (reduced thymic output) in the index patient.
- name: Decreased circulating IgA concentration
  category: Immunological
  description: >-
    Reduced serum IgA as part of the specific antibody deficiency seen in milder
    combined immunodeficiency.
  phenotype_term:
    preferred_term: Decreased circulating IgA concentration
    term:
      id: HP:0002720
      label: Decreased circulating IgA concentration
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, neutrophil function, numbers of unswitched and class-switched memory B
      cells, and serum IgA were decreased.
    explanation: >-
      Reports decreased serum IgA in a patient with biallelic LCP2 variants.
- name: Decreased class-switched memory B cell proportion
  category: Immunological
  description: >-
    Reduced numbers of unswitched and class-switched memory B cells, reflecting
    impaired T-cell help and B-cell antigen-receptor signaling.
  phenotype_term:
    preferred_term: Decreased class-switched memory B cell proportion
    term:
      id: HP:0030388
      label: Decreased class-switched memory B cell proportion
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, neutrophil function, numbers of unswitched and class-switched memory B
      cells, and serum IgA were decreased.
    explanation: >-
      Reports decreased class-switched memory B cells in a patient with biallelic LCP2
      variants.
- name: Autoimmunity
  category: Immunological
  description: >-
    Immune dysregulation with autoimmunity, reported both as early-onset
    Coombs-positive hemolytic anemia in the index infant and as autoimmunity in the
    milder combined immunodeficiency presentation.
  phenotype_term:
    preferred_term: Autoimmunity
    term:
      id: HP:0002960
      label: Autoimmunity
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a 26-year-old man who presented with specific antibody deficiency,
      autoimmunity, and inflammatory bowel disease since early childhood.
    explanation: >-
      Reports autoimmunity in an LCP2-deficient patient with immune dysregulation.
- name: Colitis
  category: Gastrointestinal
  description: >-
    Inflammatory bowel disease, part of the early-onset immune-dysregulation
    presentation.
  phenotype_term:
    preferred_term: Colitis
    term:
      id: HP:0002583
      label: Colitis
  evidence:
  - reference: PMID:37211057
    reference_title: "Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a 26-year-old man who presented with specific antibody deficiency,
      autoimmunity, and inflammatory bowel disease since early childhood.
    explanation: >-
      Reports inflammatory bowel disease in an LCP2-deficient patient.
- name: B-cell lymphoma
  category: Neoplastic
  description: >-
    EBV-driven diffuse large B-cell lymphoma developed in a homozygous
    SLP76-deficient patient, reflecting failed control of EBV-infected B cells.
  phenotype_term:
    preferred_term: EBV-related diffuse large B-cell lymphoma
    term:
      id: HP:0012191
      label: B-cell lymphoma
  evidence:
  - reference: PMID:36474126
    reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      presented with recurrent infections, failure to thrive, and severe EBV-related
      infection and proliferation. A diagnosis of diffuse large B cell lymphoma was
      made
    explanation: >-
      Reports EBV-related diffuse large B-cell lymphoma in an SLP76-deficient patient.
treatments:
- name: Hematopoietic Stem Cell Transplantation
  description: >-
    Allogeneic hematopoietic stem cell transplantation is the definitive treatment
    for the severe combined immunodeficiency form, replacing the SLP-76-deficient
    hematopoietic compartment. The index infant underwent haplo-identical HSCT but
    died of transplant-related complications; HSCT is the standard curative approach
    for T-B+ SCID generally.
  treatment_term:
    preferred_term: hematopoietic stem cell transplantation
    term:
      id: NCIT:C15431
      label: Hematopoietic Cell Transplantation
  therapeutic_modality: CELL_THERAPY
  target_mechanisms:
  - target: Loss of SLP-76 Adaptor Function
    treatment_effect: RESTORES
    description: >-
      Allogeneic HSCT replaces the SLP-76-deficient hematopoietic compartment with
      donor cells that express functional SLP-76, restoring the adaptor at the root of
      the disease mechanism.
- name: Antimicrobial Prophylaxis and Treatment
  description: >-
    Broad antibacterial, antiviral, and antifungal prophylaxis and treatment to
    manage the recurrent and opportunistic infections of the combined immune and
    neutrophil defect.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: anti-infective agent
      term:
        id: NCIT:C254
        label: Anti-Infective Agent
  therapeutic_modality: SMALL_MOLECULE
  target_mechanisms:
  - target: Recurrent infections
    treatment_effect: INHIBITS
    description: >-
      Antibacterial, antiviral, and antifungal agents treat and prevent the recurrent
      opportunistic infections that result from the combined immune and neutrophil
      defect.
- name: Immunoglobulin Replacement Therapy
  description: >-
    Immunoglobulin replacement supports the humoral immunodeficiency (antibody
    deficiency, reduced IgA and memory B cells) seen in these patients.
  treatment_term:
    preferred_term: immunoglobulin replacement therapy
    term:
      id: NCIT:C62710
      label: Immunoglobulin Therapy
  therapeutic_modality: PROTEIN_REPLACEMENT
  target_mechanisms:
  - target: Combined T- and B-Cell Immunodeficiency
    treatment_effect: BYPASSES
    description: >-
      Passive immunoglobulin replaces the antibody the patient cannot make, bypassing
      the humoral arm of the combined immunodeficiency rather than correcting the
      underlying signaling defect.
- name: Supportive and Oncologic Care
  description: >-
    Supportive care and, when EBV-driven lymphoproliferation or lymphoma develops,
    directed oncologic therapy. One reported patient developed and succumbed to
    EBV-related diffuse large B-cell lymphoma.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: B-cell lymphoma
    treatment_effect: INHIBITS
    description: >-
      Directed oncologic therapy targets the EBV-driven B-cell lymphoma that arises
      as a downstream complication of the immunodeficiency.
animal_models:
- name: Slp76-null mouse (Lcp2 knockout)
  species: Mouse
  genotype: Slp76 (Lcp2) null (homozygous knockout)
  publication: PMID:9695951
  description: >-
    The germline Slp76-null mouse, generated by homologous recombination, was the
    original in vivo model of SLP-76 loss. It exhibits impaired viability, a profound
    thymic developmental block, and hemorrhage. It informs the human disease but
    diverges from it in two ways relevant to IMD81: the complete null causes an
    absolute developmental block with no peripheral T cells (human hypomorphic alleles
    leave dysregulated peripheral T cells), and B-cell development is entirely normal
    (human patients have a B-cell antigen-receptor signaling defect).
  evidence:
  - reference: PMID:9695951
    reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We generated a SLP-76 null mutation in mice by homologous recombination in
      embryonic stem cells to evaluate the role of SLP-76 in T cell development and
      activation.
    explanation: >-
      Establishes the Slp76-null mouse as the in vivo model of SLP-76 loss informing
      this disease.
  modeled_mechanisms:
  - target: Impaired Thymic T-Cell Development
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      The null reproduces the SLP-76-dependent thymic developmental block, with
      absence of double-positive thymocytes and peripheral T cells.
    limitations: >-
      The complete null causes an absolute block with no peripheral T cells, whereas
      human hypomorphic/leaky alleles leave dysregulated peripheral T cells (skewed
      toward CD8 TEMRA), so the null overstates the human developmental defect.
    readouts:
    - name: Double-positive thymocyte and peripheral T-cell content
      target: Impaired Thymic T-Cell Development
      direction: DECREASED
      interpretation: >-
        Absence of CD4+8+ double-positive thymocytes and of peripheral T cells is the
        structural correlate of the thymic-development node in this model.
      evidence:
      - reference: PMID:9695951
        reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Analysis of lymphoid cells revealed a profound block in thymic development
          with absence of double-positive CD4+8+ thymocytes and of peripheral T cells.
        explanation: >-
          Reports the thymic developmental block and loss of peripheral T cells
          measured in this model.
    evidence:
    - reference: PMID:9695951
      reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        These results indicate that SLP-76 collects all pre-TCR signals that drive the
        development and expansion of double-positive thymocytes.
      explanation: >-
        Supports treating this model as informative for the thymic T-cell development
        node.
  - target: Combined T- and B-Cell Immunodeficiency
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    description: >-
      The Slp76-null mouse does not reproduce the B-cell arm of the human combined
      immunodeficiency: murine B-cell development is entirely normal.
    limitations: >-
      B-cell development is normal in the null mouse, whereas human IMD81 patients have
      a B-cell antigen-receptor signaling defect with reduced class-switched memory B
      cells and antibody deficiency; the null therefore misses the B-cell component of
      the human phenotype.
    evidence:
    - reference: PMID:9695951
      reference_title: "Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        B cell development was normal.
      explanation: >-
        Documents that B-cell development is normal in the null mouse, the divergence
        from the human B-cell phenotype.
experimental_models:
- name: SLP76-deficient Jurkat-derived T-cell line (J14)
  experimental_model_type: CELL_LINE
  publication: PMID:33231617
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_source: >-
    J14, a SLP76-deficient subline of the Jurkat human leukemic T-cell line,
    reconstituted with wild-type or patient-mutant SLP-76 to model and rescue the
    signaling defect.
  description: >-
    The J14 line is the classical in vitro system for dissecting SLP-76 function
    downstream of the TCR. Reconstituting it with the patient's SLP-76 mutant
    reproduces the reduced proximal TCR signaling, and ectopic wild-type SLP-76
    rescues it, linking the specific mutation to the signaling phenotype.
  evidence:
  - reference: PMID:33231617
    reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we characterized aspects of the patient's immune phenotype, modeled them with an
      SLP76-deficient Jurkat-derived T cell line, and rescued some consequences using
      ectopic expression of wild-type SLP76.
    explanation: >-
      Establishes the J14 line as the model used to reproduce and rescue the patient's
      TCR-signaling phenotype.
  modeled_mechanisms:
  - target: Impaired Proximal TCR Signaling
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reconstituting J14 with the patient's SLP-76 mutant reproduces the reduced
      proximal TCR signaling (ERK phosphorylation, CD69 induction, calcium
      mobilization).
    limitations: >-
      A transformed leukemic line with fixed-promoter cDNA expression, not primary
      cells; the clonal, supraphysiological context limits quantitative transfer to
      the patient's cells.
    readouts:
    - name: TCR-induced ERK phosphorylation, CD69 expression and calcium mobilization
      target: Impaired Proximal TCR Signaling
      direction: DECREASED
      interpretation: >-
        Reduced ERK, CD69 and calcium responses in the mutant-reconstituted line are
        the readouts of the proximal TCR-signaling node.
      evidence:
      - reference: PMID:33231617
        reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          were moderately reduced in the mutant SLP76-expressing Jurkat cells, and this
          reduction was statistically significant.
        explanation: >-
          Reports the statistically significant reduction of ERK, CD69 and calcium
          responses in the mutant-reconstituted J14 line.
    evidence:
    - reference: PMID:36474126
      reference_title: "SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Downstream TCR signaling events, including ERK1/2 phosphorylation, CD69
        expression, and Ca2 + mobilization, were reduced in cells harboring the reported
        mutation
      explanation: >-
        A second patient's SLP76 mutation, modeled in the same J14 line, likewise
        reduces proximal TCR signaling, supporting this model for the node.
  - target: Impaired Proximal TCR Signaling
    relationship: RESCUES
    fidelity: MODERATE
    description: >-
      Ectopic expression of wild-type SLP-76 in the deficient line rescues the
      signaling consequences, confirming the defect is SLP-76-dependent and reversible.
    limitations: >-
      Rescue is partial and demonstrated in a leukemic cell line rather than in
      patient primary cells or in vivo.
    evidence:
    - reference: PMID:33231617
      reference_title: "Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        rescued some consequences using ectopic expression of wild-type SLP76.
      explanation: >-
        Demonstrates that restoring wild-type SLP-76 rescues the signaling phenotype,
        establishing SLP-76 dependence of the node.
discussions:
- discussion_id: slp76_mouse_human_bcell_and_thymic_divergence
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    The germline Slp76-null mouse shows a complete thymic block with no peripheral T
    cells and entirely normal B-cell development, whereas human IMD81 patients retain
    (dysregulated) peripheral T cells and have a B-cell antigen-receptor signaling
    defect with reduced memory B cells and antibody deficiency. Does the complete-null
    mouse therefore fail to model the human B-cell arm and overstate the T-cell
    developmental block, and is the human phenotype instead captured by hypomorphic
    Lcp2 alleles?
  attaches_to:
  - pathophysiology#Impaired Thymic T-Cell Development
  - pathophysiology#Combined T- and B-Cell Immunodeficiency
  rationale: >-
    This is a model-evidence-exists-and-diverges situation, not an absence of data.
    The complete Slp76 null causes an absolute block at the double-negative 3 stage
    with no peripheral T cells and normal B-cell development, while human patients
    carry hypomorphic or leaky alleles (splice, frameshift, proline-rich-domain
    missense) that leave residual SLP-76 and, consequently, dysregulated peripheral T
    cells skewed toward CD8 TEMRA plus a B-cell receptor signaling defect the null
    does not show. Homozygous Lcp2 splice-hypomorph mice that retain about 10% of
    wild-type SLP-76 protein reproduce the human pattern far better (a partial thymic
    block with dysregulated peripheral T cells), indicating that model fidelity to
    IMD81 depends on residual protein rather than on complete ablation. The B-cell arm
    of the human disease is therefore best modeled in patient cells and in the J14
    line, not in the null mouse.
  proposed_experiments:
  - experiment_id: exp_slp76_hypomorph_knockin
    name: Knock-in mouse carrying a human hypomorphic LCP2 allele
    description: >-
      Generate a mouse expressing an actual human IMD81 hypomorphic allele (e.g. the
      proline-rich-domain missense or the leaky splice variant) rather than a complete
      null, and test whether it reproduces the human combination of dysregulated
      peripheral T cells and a B-cell antigen-receptor signaling defect.
  - experiment_id: exp_slp76_bcr_signaling
    name: B-cell antigen-receptor signaling in a residual-protein model
    description: >-
      Measure BCR-induced calcium flux and class-switch/memory B-cell generation in a
      residual-SLP-76 model to determine whether the human B-cell phenotype requires
      partial rather than complete loss of the adaptor.
šŸ“š

References & Deep Research

References

4
Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects.
No top-level findings curated for this source.
Combined immunodeficiency and impaired PI3K signaling in a patient with biallelic LCP2 variants.
No top-level findings curated for this source.
SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma.
No top-level findings curated for this source.
Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76.
No top-level findings curated for this source.